Sangamo Biosciences reported $5.05M in Trade Debtors for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Alnylam Pharmaceuticals ALNY:US USD 184.51M 42.24M
Amgen AMGN:US USD 5.56B 237M
Avrobio Inc AVRO:US USD 2.98M 24K
Bayer BAYN:GR EUR 14.75B 3.64B
Biocryst Pharmaceuticals BCRX:US USD 42.61M 1.12M
Biogen BIIB:US USD 1.98B 19.3M
Biomarin Pharmaceutical BMRN:US USD 419.62M 46.88M
Gilead Sciences GILD:US USD 4.78B 423M
GlaxoSmithKline GSK:LN GBP 7.46B 636M
Intercept Pharmaceuticals ICPT:US USD 26.17M 1.35M
IONIS PHARMACEUT IONS:US USD 6.64M 106K
Karyopharm Therapeutics KPTI:US USD 27.45M 3.97M
Novartis NOVN:VX USD 8.33B 346M
Omeros OMER:US USD 61.6M 3.32M
Roche Holding ROG:VX 11.08B 48M
Sangamo Biosciences SGMO:US USD 5.05M 1.24M
Sarepta Therapeutics SRPT:US USD 223.45M 6.82M
Ultragenyx Pharmaceutical RARE:US USD 31.16M 6.04M